Correlation Between Foghorn Therapeutics and Monte Rosa
Can any of the company-specific risk be diversified away by investing in both Foghorn Therapeutics and Monte Rosa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Foghorn Therapeutics and Monte Rosa into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Foghorn Therapeutics and Monte Rosa Therapeutics, you can compare the effects of market volatilities on Foghorn Therapeutics and Monte Rosa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Foghorn Therapeutics with a short position of Monte Rosa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Foghorn Therapeutics and Monte Rosa.
Diversification Opportunities for Foghorn Therapeutics and Monte Rosa
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Foghorn and Monte is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Foghorn Therapeutics and Monte Rosa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Monte Rosa Therapeutics and Foghorn Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Foghorn Therapeutics are associated (or correlated) with Monte Rosa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Monte Rosa Therapeutics has no effect on the direction of Foghorn Therapeutics i.e., Foghorn Therapeutics and Monte Rosa go up and down completely randomly.
Pair Corralation between Foghorn Therapeutics and Monte Rosa
Given the investment horizon of 90 days Foghorn Therapeutics is expected to under-perform the Monte Rosa. But the stock apears to be less risky and, when comparing its historical volatility, Foghorn Therapeutics is 3.5 times less risky than Monte Rosa. The stock trades about -0.07 of its potential returns per unit of risk. The Monte Rosa Therapeutics is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest 517.00 in Monte Rosa Therapeutics on August 28, 2024 and sell it today you would earn a total of 329.00 from holding Monte Rosa Therapeutics or generate 63.64% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Foghorn Therapeutics vs. Monte Rosa Therapeutics
Performance |
| Timeline |
| Foghorn Therapeutics |
| Monte Rosa Therapeutics |
Foghorn Therapeutics and Monte Rosa Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Foghorn Therapeutics and Monte Rosa
The main advantage of trading using opposite Foghorn Therapeutics and Monte Rosa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Foghorn Therapeutics position performs unexpectedly, Monte Rosa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Monte Rosa will offset losses from the drop in Monte Rosa's long position.| Foghorn Therapeutics vs. Eliem Therapeutics | Foghorn Therapeutics vs. HCW Biologics | Foghorn Therapeutics vs. Scpharmaceuticals | Foghorn Therapeutics vs. Milestone Pharmaceuticals |
| Monte Rosa vs. Nkarta Inc | Monte Rosa vs. Lyell Immunopharma | Monte Rosa vs. Generation Bio Co | Monte Rosa vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Complementary Tools
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum |